Vimarsana
Biggest News Aggregation in the World

Page 4 - Stroke Statistics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stroke Statistics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stroke Statistics Today - Breaking & Trending Today

Research reveals high prevalence of abnormal heart rhythms in adults with congenital heart disease - Vimarsana News

Research reveals high prevalence of abnormal heart rhythms in adults with congenital heart disease

Almost 1 in 5 adults with congenital heart disease living in Israel had or developed an abnormal heart rhythm/arrhythmia during a five-year study, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 - Vimarsana News

Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24

Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanism of ActionDUBLIN, Ireland and BRIDGEWATER, N.J., April 08, 2024 -- Amarin Corporation plc today highlighted three data...

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups - Vimarsana News

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

-- Findings Presented on VASCEPA/VAZKEPA Utility in REDUCE-IT Patient Subgroups by Baseline High/Low Lp, LDL-C Levels -- -- Lp Results Published Simultaneously in the Journal of the American...

Scientists Discover Secondary Benefit of Weight Loss Medication Tirzepatide: Lowering Systolic Blood Pressure - Vimarsana News

Scientists Discover Secondary Benefit of Weight Loss Medication Tirzepatide: Lowering Systolic Blood Pressure

A new study reveals that weight loss medication leads to reductions in blood pressure levels during both day and night. Recent research published in Hypertension, a journal of the American Heart Association, reveals that tirzepatide, a new weight loss drug, substantially reduced systolic blood pres

Embrace Heart Health and the Power of Walnuts During American Heart Month - Vimarsana News

Embrace Heart Health and the Power of Walnuts During American Heart Month

/PRNewswire/ -- A new survey1 from California Walnuts just revealed that only one-fifth of Americans (19%) say they eat enough walnuts to support a diet for...